CAS: 13824-96-9; Sodium Hypobromite

该化合物是一种无机化合物,配有化学配方NaBRO.它是一种黄色的固体,通常以溶解形式遇到.作为一种强氧化剂,它以漂白和消毒特性而著称,它有助于各种应用,包括水处理和有机合成.它溶于水中,它能释放低溴酸,有助于其抗微生物活动.钠低溴酸相对不稳定,可以降解,特别是当接触热或光时,这可能导致溴气释放.在处理这一化合物时,必须采取安全防范措施,因为它可能腐蚀和刺激皮肤和粘膜.此外,它应储存在一个冷干的地方,远离不相容的物质,例如强酸和有机材料,以防止危险反应.

结构式图片

合成工艺路线路线简述

    专利信息


    专利号:US-2023339844-A1
    优先权日:2020-09-17
    标题:A process for the synthesis of anthranilic acid/amide compounds and intermediates thereof
    发明人:MAHAPATRA TRIDIB; PATRA PRANAB KUMAR; KLAUSENER ALEXANDER G M; MAL SANJIB; SHARMA RAJU
    权利人:PI INDUSTRIES LTD; PI INDUSTRIES LTD
    摘要:The present invention disclosed a process for the synthesis of compound of formula (Z) or a salt thereof, n n n n n n n n n n wherein, R, R 1 , R 2 , R 3 and R 10 are as defined in the detailed description. The process further comprises the synthesis of an anthranilic diamide compound of formula (I).

    专利号:US-8212077-B2
    优先权日:2008-08-05
    标 题:Process for the synthesis of agomelatine
    发明人:HARDOUIN CHRISTOPHE; LECOUVE JEAN-PIERRE; BARAGNIER NICOLAS
    权利人:HARDOUIN CHRISTOPHE; LECOUVE JEAN-PIERRE; BARAGNIER NICOLAS; SERVIER LAB
    摘要:Process for the industrial synthesis of the compound of formula (I)

    专利号:EP-1363951-B1
    优先权日:2000-12-07
    标 题 :Polynuclear complex fe(iii) with pullulan oligomers, process of its obtaining, and pharmaceutical preparations on the basis of the complex
    发明人:ILIC LJUBOMIR; RISTIC SUZANA; CAKIC MILORAD; NIKOLIC GORAN; STANKOVIC SLOBODAN
    权利人:AD ZDRAVLJE FARMACEUTSKO HEMIJ
    摘要:A polynuclear complex of pullulan oligomers of formula (I): wherein n = (100-8200), obtained by process of synthesis of soluble pullulan with insoluble iron (III)-hydroxyde of formula (II): wherein n=(900). The process of synthesis is characterized by technical simplicity and economy. In accordance with suggested process, first of all, preparation of pullulan for synthesis, including its characterization (determination of RG, Mw, Mn, [θ]) is carried out, and subsequently its hydrogenation is carried out in order to eliminate reducing groups, iron(III)-hydroxyde gel is prepared, and synthesis of the complex can start. Obtained complex is afterwards prepared for pharmacological use and it is subjected to the subsequent physical and chemical processes of purification. The preparation obtained in such a way is used for prevention and treatment of syderopenic anemia in human and veterinay medicine.

    专利号:WO-2013001322-A1
    优先权日:2011-06-30
    标 题:PROCESS FOR THE SYNTHESIS OF (5α,17β)-N-[(2,5-BIS(TRIFLUOROMETHYL)-PHENYL]-3-OXO-4-AZA-5-ANDROST-1-ENE-17-CARBOXAMIDE
    发明人:SOEROES BELA; TUBA ZOLTAN; GALIK GYOERGY; MAHO SANDOR; BALOGH LASZLO; VINCZE PETER; HORVATH JANOS; KOVACS ANDRAS; BENI ZOLTAN; VARGA FRIGYES
    权利人:RICHTER GEDEON NYRT; SOEROES BELA; TUBA ZOLTAN; GALIK GYOERGY; MAHO SANDOR; BALOGH LASZLO; VINCZE PETER; HORVATH JANOS; KOVACS ANDRAS; BENI ZOLTAN; VARGA FRIGYES
    摘要:The synthesis consists of reaction steps as follows: oxidizing the α,β-unsaturated ketone system of ring 'A' of pregn-4-ene-3,20-dion- of formula (II) with sodium metaperiodate in tert-butanol in the presence of potassium permanganate and alkali metal carbonate, reacting the obtained 3,5-seco acid with an ester of chloroformic acid in the presence of tertier organic base below 0°C, reacting the obtained new compound after isolation or without isolation with ammonia or ammonium acetate, cyclization of the resulting carboxamides with an acid, cathalytic hydrogenating the obtained ene lactame, and oxidizing the side chain at position 17 of the obtained pregnane compound with an alkali metal hypobromide in aqueous dioxane below 10°C. Thereafter on one hand the obtained (5α,17β)-3-oxo-4-aza-5-androstane-17-carboxylic acid is reacted with chloroformic acid ester, the obtained new compound is reacted with 2,5-bis(trifluoromethyl)-aniline in the presence of a Lewis acid, the obtained amide is reacted with trimethyl chlorosilane in inert atmosphere in the presence of Î?,Î?,Î?',Î?'-tetramethyl-ethylendiamine, then en excess iodine is added to the reaction mixture and the product of the iodination reaction is crystallized from acetonitrile, then the obtained 2-iodo-3-oxo-4-aza-17β-carboxamide is reacted with potassium tert-butylate to furnish final product. On the other hand, (5α,17β)-3-oxo-4-aza-5-androstane-17-carboxylic acid is transformed into methylester by known method, this latter is transformed into methyl (2α,5α,17β)-2-iodo-3-oxo-4-aza-5-androstane-17-carboxylate according to known method, the obtained compound is reacted with potassium-tert-butylate, the obtained (5α,17β)-3-oxo-4-aza-5-androst-1-ene-17-carboxylic acid is reacted with an ester of chloroformic acid, then the obtained new compound is coupled with 2,5-bis(trifluoromethyl)-aniline in the presence of a Lewis acidcatalyst to gain final product.

    专利号:US-4777257-A
    优先权日:1983-08-25
    标题:Certain tetrahydronaphthyl or indanylcarboxylates and derivatives thereof which inhibit the synthesis of thromboxane
    发明人:KANAO MUNEFUMI
    权利人:DAIICHI SEIYAKU CO
    摘要:Benzocycloalkane derivatives of the formula (I) ##STR1## wherein: Z represents a methylene group or an ethylene group, either one of R 1 and R 2 represents --(CH 2 ) m --COOR 3 and the other represents ##STR2## wherein R 3 represents a hydrogen atom or an alkyl group having 1 to 6 carbon atoms, n represents an interger of 1 to 6 and m represents an interger of 0 to 5, and the physiologically acceptable salts thereof; having a strong and selective inhibition activity of thromboxane A 2 synthesis.

    专利号:US-6207863-B1
    优先权日:1998-08-11
    标题 :Synthesis of haloformimine compounds
    发明人:BERRIER JOHN VINCENT; UMARVADIA ASHUTOSH SUMANTRAI
    权利人:ROHM & HAAS
    摘要:Disclosed is an improved method for the preparation of highly pure haloformimine compounds in high yields by reacting a formimine compound in a solvent with a halogenating agent while maintaining the pH of the halogenation reaction in the range of 2 to 5. The pH of the reaction may be maintained by a variety of means, such as by the addition of a base.
    江西伯业医药科技有限公司
    小微企业
    信用代码: 91360502MA3898AK86法定代表人:胡义建
    注册资本:102.2万(元)企业类型:有限责任公司(非自然人投资或控股的法人独资)
    成立日期:2018-11-30登记机关:新余市渝水区市场监督管理局
    注册地址: 江西省新余市渝水区解放东路19号
    原料药、化工原料、实验室试剂、化妆品原料(不含危险化学品及易制毒品)的研发、销售及技术咨询、技术转让、技术服务;食品添加剂、饲料添加剂、实验仪器的销售;对甲苯磺酰氯、N,N-二甲基-1,3-二氨基丙烷、2-氯-5-硝基苯甲酸......依法须经批准的项目,经相关部门批准后方可开展经营活动)
    免费会员展台
    https://www.boyepharm.com
    企业联系电话:15377010747👤
    📞 江西伯业医药科技有限公司
    销售经理: 李经理
    电话:15387090420
    微信号:15387090420
    E-mail:yeqim@boyechemicals.com
    ⚠️ 声明: 咨询或交易时请注意风险评估和信息核实,百琢研不参与任何交易。

    地址: 江西省新余市渝水区解放东路19号
    常规和库存产品20产品总量: 946

    平台资质认证✓营业执照✓危化许可证
    次溴酸钠溶液
    13824-96-9
    产品图片其他备注: 专业从事特色医药合成中间体关键物料研发及产业化的高技术企业.
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1007/bf01952278
    摘要:Loriette C, Pierre Y, Chatagner F. Effect of dietary cholic acid and cholesterol on liver and kidney cystathionase and cysteine sulfinate decarboxylase activities and taurine concentrations in the rat. Cellular and Molecular Life Sciences. 1980 Mar;36(3):285–6. doi: 10.1007/bf01952278.
    参考文献:10.1007/s002449910001
    摘要:Ueno H, Oishi K, Sayato Y, Nakamuro K. Oxidative Cell Damage in Kat-Sod Assay of Oxyhalides as Inorganic Disinfection By-Products and Their Occurrence by Ozonation. Archives of Environmental Contamination and Toxicology. 2000 Jan 01;38(1):1–6. doi: 10.1007/s002449910001.
    参考文献:10.1007/bf02160621
    摘要:Laarhoven WH, Nivard RJF, Havinga E. Estrogenic activity and steric hindrance to coplanarity of alkyl substituted 4,4′-dimethoxystilbenes. Cellular and Molecular Life Sciences. 1961 May;17(5):214–5. doi: 10.1007/bf02160621.
    参考文献:10.1007/s00726-004-0097-1
    摘要:Olszanecki R, Marcinkiewicz J. Taurine chloramine and taurine bromamine induce heme oxygenase-1 in resting and LPS-stimulated J774.2 macrophages. Amino Acids. 2004 Aug;27(1):29–35. doi: 10.1007/s00726-004-0097-1.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知